ALLERGAN PLC (NYSE:AGN) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compulsory Arrangements of Certain Officers

On December18, 2017, Allergan plc (the “Company”) announced that on December15, 2017, Robert Stewart informed the Company of his intention to resign as Chief Operating Officer, effective mid-January 2018, to become President and Chief Executive Officer of Amneal Pharmaceuticals LLC starting January 25, 2018.